Abcam Establishes New Direct Service for Australia and New Zealand
News Aug 12, 2014
Abcam plc announced today it has established a direct service to Australia and New Zealand. The move signifies the importance of this region and Abcam’s focus on providing the best products and services to accelerate the pace of researchers’ scientific discoveries.
The new service enables customers in Australia and New Zealand to order their research tools directly from Abcam rather than through a distributor. These customers will also benefit from direct technical support, and delivery times reduced by up to 50% from order to delivery.
Philippe Cotrel, Commercial Director, Abcam, said: “I’m delighted that we can offer an enhanced service to our customers in Australia and New Zealand. A direct service will enable us to develop closer relationships with our customers, and ensure we are fully meeting their research needs.”
Abcam’s experienced technical and customer support teams and in-house manufacturing facilities provide researchers worldwide with high-performance products that they can trust, such as RabMAb® primaries.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Herpesvirus and Alzheimer's Link: High abundance of Herpes genes in postmortem Alzheimer's brain tissueNews
Data from three different brain banks to suggest that human herpesviruses are more abundant in the brains of Alzheimer's patients and may play a role in regulatory genetic networks that are believed to lead to the disease.READ MORE